Core Viewpoint - The company Jianfa Zhixin (301584.SZ) expects a net profit attributable to shareholders of 242 million to 296 million yuan for 2025, representing a year-on-year growth of 6.00% to 29.65% [1] Financial Performance - The net profit after deducting non-recurring gains and losses is projected to be between 232 million and 286 million yuan, indicating a year-on-year increase of 3.77% to 27.93% [1] - The company has optimized its financial structure, resulting in a year-on-year decrease in interest-bearing debt [1] - Through communication and negotiation with financial institutions, the company has successfully reduced financing costs, leading to a decrease in financial expenses and positively impacting net profit [1] Business Development - The company's medical consumables centralized operation (SPD) business has maintained rapid growth, contributing to a higher gross profit margin and enhancing overall profitability [1]

Core Viewpoint - The company Jianfa Zhixin expects a net profit attributable to shareholders of 242 million to 296 million yuan for 2025, representing a year-on-year growth of 6% to 29.65% due to the rapid development of its medical consumables centralized operation (SPD) business, which has a high gross profit margin [1] Group 1 - The company's SPD business is experiencing rapid growth, contributing significantly to overall profitability [1] - The gross profit margin of the SPD business is high, enhancing the company's overall profitability [1] - The company is optimizing its financial structure, resulting in a year-on-year decrease in interest-bearing liabilities [1] Group 2 - The company has engaged in communication and negotiation with financial institutions to reduce financing costs, positively impacting net profit [1] - Financial expenses have decreased year-on-year, further contributing to the increase in net profit [1]